Exclusive Summary

• Pranoprofen eye drops are off-patent in major global markets, offering broad opportunities for generic entry, especially in underserved regions.
• The product targets common ophthalmic conditions like post-operative inflammation and allergic conjunctivitis, with a vast global patient base and consistent demand for effective topical anti-inflammatory agents.
• As an NSAID, it is widely recommended in global clinical guidelines for ophthalmic inflammation, securing a stable clinical position as a first-line or adjunctive treatment.
• Compared to high-priced originator drugs, our Pranoprofen eye drops offer a significant cost advantage, providing a more competitive product option for overseas markets.
• Chinese manufacturers can provide products with international quality standards and registration experience, ensuring quality and compliance for global market access.